今开{{formartData(data.f46,data.f59,2)}} 最高{{formartData(data.f44,data.f59,2)}} 最低{{formartData(data.f45,data.f59,2)}} 换手{{formartUnit(formartData(data.f168,data.f152,2),'%')}} 总手{{formartUnit(data.f47,'calc',1)}} 金额{{formartUnit(data.f48,'calc',2)...
Get real-time updates on Seres Therapeutics, Inc. Common Stock (MCRB) stock quotes, trades, and more. Make informed investments with Nasdaq.
Wall Street Analysts Believe Seres Therapeutics (MCRB) Could Rally 713.09%: Here's is How to Trade May 16, 2025 • Zacks Stocks $MCRB stock is up 24% today. Here's what we see in our data. Apr 23, 2025 • Quiver Quantitative Stocks Down -48.7% in 4 Weeks, Here's Why ...
The Investor Relations website contains information about Seres Therapeutics's business for stockholders, potential investors, and financial analysts.
Seres'news, events and other information can be found throughout the pages below. None2025202420232022202120202019201820172016201520142013 2025
Insider trades for Seres Therapeutics, Inc. (MCRB). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long and Short Trading Ideas using Insider Transaction Data.
Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on September 6, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity gr
A downtrend has been apparent in Seres Therapeutics (MCRB) lately. While the stock has lost 32.6% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This co
Seres Therapeutics, Inc. Common Stock (MCRB) After-Hours Data is currently not available 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4:00 - 8:00) 交易。做市商和 ECN 严格自愿参与,因此,这些时段的流动性和价格会比较低。在这种环境下,股票价格也可能波动更快...